Candidiasis: Implications for intensivists and pulmonologists

Seminars in Respiratory and Critical Care Medicine

Volumn 18, Issue 3, 1997, Pages 225-234

  Gelfand, Michael S ^a,b  

^a Methodist Hospitals of Memphis   (United States)

^b NONE   (United States)

Author keywords

Candidemia; Candidiasis; Empiric presumptive therapy

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN B; FLUCONAZOLE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; LIPOSOME; NYSTATIN; PNEUMOCANDIN DERIVATIVE;

ABDOMINAL INFECTION; CANDIDA; CANDIDIASIS; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; CONFERENCE PAPER; DRUG RESISTANCE; EYE INFECTION; FUNGEMIA; HEART DISEASE; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; LUNG MYCOSIS; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; URINARY TRACT INFECTION; VASCULAR DISEASE;

EID: 0030746392     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1070992     Document Type: Conference Paper

References (86)

1. Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: An epidemic of the 1980s. Clin Infect Dis 1995;21:397-904
2. Edwards JE. Invasive Candida infections: Evolution of a fungal pathogen. N Engl J Med 1991;325:1060-2
3. Fridkin SK, Jarvis WR Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511
4. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20: 1526-30
5. Edwards JE. Candida species. In Mandell GL, Bennett JE, Dolin R eds. Principles and Practice of Infectious Diseases, 4th ed New York, Churchill Livingstone Publishers, 1995, 2289-306
6. Bodey GP, ed. Candidiasis, 2nd ed. New York, Raven Press, 1993
7. Wingard JR, Merz WG, Saral R. Candida tropicalis: A major pathogen in immunocompromised patients. Ann Intern Med 1979;91:539-43
8. Weems JJ. Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992;14:756-66
9. McQuillen DP, Zingman BS, Meunier F, Levitz SM. Invasive infections due to Candida krusei: Report of ten cases of fungemia that include three cases of endophthalmitis. Clin Infect Dis 1992;14:472-8
10. Wingard JR Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995;20:115-25
11. Pfaller MA. Nosocomial candidiasis: Emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996, 22 (Suppl 2):S89-94
12. Nguyen MH, PeacockJE, Morris AJ, et al. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996;100:614-23
13. Voss A, Hollis RJ, Pfaller MA, et al Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994;32:975-80
14. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-8
15. Burnie JP, Odds FC, Lee W, et al. Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Br Med J 1985;290:746-8
16. Vaudrv WL, Tierney AJ, Wenman WM. Investigation of a cluster of systemic Candida albicans infections in neonatal intensive care unit. J Infect Dis 1988;158:1375-9
17. Finkelstein R, Reinhertz G, Hashman N, Merzbach D. Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit. Infect Control Hospital Epidemiol 1993;14: 587-90
18. Strausbaugh LJ, Sewell DL, Ward TT, et al. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol 1994;32:2299-300
19. Isenberg HD, Tucci V, Cintron F, et al. Single-source out-break of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 1989;27:2426-8
20. Pertowski CA, Baron RC, Lasker BA, et al. Nosocomial outbreak of Candida albicans sternal wound infections following cardiac surgery traced to a scrub nurse. J Infect Dis 1995;172:817-22
21. Doebbeling BN, Hollis RJ. Isenberg HD, et al. Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infections. J Clin Microbiol 1991;29:1268-70
22. Dembry LM, Vazquez JA, Zervous MJ. DNA analysis in the study of the epidemiology of nosocomial candidiasis. Infect Control Hospital Epidemiol 1994;15:48-53
23. Klotz SA. Fungal adherence to the vascular compartment: A critical step in the pathogenesis of disseminated candidiasis. Clin Infect Dis 1992;14:340-7
24. Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: From the laboratory to the bedside. Clin Infect Dis 1996;22(Suppl 2): S73-88
25. Krause W, Matheis H, Wulf K. Fungaemia and funguria after oral administration of Candida albicans. Lancet 1969;22 (March):598-9
26. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery 1980;88: 524-30
27. Solomkin JS, Flohr A, Simmons RL. Candida infections in surgical patients. Ann Surg 1982;195:177-85
28. Calandra T, Bille J, Schneider R, et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989;16:(December):1437-9
29. Jones JM. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 1990;3:32-45
30. Walsh TJ, Hathron JW, Sobel JD, et al. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 1991;324: 1026-31
31. Christensson B, Wiebe T, Pehrson C, Larsson L. Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of d-arabinitol/1-arabinitol ratios in urine. J Clin Microbiol 1997;35:636-40
32. Buchman AL, Lee S, Miller J, et al. Candida fungemia diagnosed from peripheral blood smear. JAMA 1988;260: 2926
33. Wey SB, Mori M, Pfaller MA, et al. Risk factors for hospital-acquired candidemia. Arch Intern Med 1989;149:2349-53
34. Wey SB, Mori M, Pfaller MA, et al. Hospital-acquired candidemia: The attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-5
35. Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-21
36. Bodey GP, Luna M. Skin lesions associated with disseminated candidiasis. JAMA 1974;229:1466-8
37. Jarowski CI, Fialk MA, Murray HW, et al. Fever, rash, and muscle tenderness: A distinctive clinical presentation of disseminated candidiasis. Arch Intern Med 1978;138: 544-6
38. Lipton SA, Hickey WF, Morris JH, Loscalzo J. Candidal infection in the central nervous system. Am J Med 1984;76: 101-8
39. Arndt CAS, Walsh TJ, McCully CL, et al. Fluconazole penetration into cerebrospinal fluid. Implications for treating fungal infections of the central nervous system. J Infect Dis 1988;157:178-80
40. Masur H, Rosen PP, Armstrong D. Pulmonary disease caused by Candida species Am J Med 1977;63:914-24
41. Chu FE, Armstrong D. Candida species pneumonia. In Sarosi GA, Davies SF eds. Fungal Diseases of the Lung. New York, Raven Press, 1993;125-31
42. DuBois PJ, Lyerowitz RL, Allen CM. Pathoradiologic correlation of pulmonary candidiasis in immunosuppressed patients. Cancer 1977;40:1026-36
43. Rose HD, Sheth NK. Pulmonary candidiasis: A clinical and pathological correlation Arch Intern Med 1978;138:964-5
44. Buff SJ, McLelland R, Gallis HA, et al. Candida albicans pneumonia: Radiographic appearance. Am J Roentgenol 1982; 138:645-8
45. Haron E, Vartivarian S, Anaissie E, et al. Primary Candida pneumonia: Experience at a large cancer center and review of the literature. Medicine 1993;72:137-42
46. Schiffman RL, Johnson TS, Weinberger SE, et al. Candida lung abscess: Successful treatment with amphotericin B and 5-flucvtosine. Am Rev Respir Dis 1982;125:766-8
47. Watanakunakorn C. Acute pulmonary mycetoma due to Candida albicans with complete resolution. J Infect Dis 1983; 148:1131
48. Shelly MA, Poe RH, Kapner LB. Pulmonary mycetoma due to Candida albicans: Case report and review. Clin Infect Dis 1996;22:133-5
49. von Eiff M, Zuhldorf M, Roos N, et al. Pulmonary fungal infections in patients with hematological malignancies - diagnostic approaches. Ann Hematol 1995;70:135-41
50. Ogmbene FP. Diagnosis of fungal pneumonias. In Shelhamer JH, moderator. The laboratory evaluation of opportunistic pulmonary infections. Ann Intern Med 1996;124: 585-99
51. Pisani RJ, Wright AJ. Clinical utility of bronchoalveolar lavage in immunocompromised hosts. Mayo Clin Proc 1992;67:221-7
52. Nguyen MH, Nguyen ML, Yu VL, et al. Candida prosthetic valve endocarditis: Prospective study of six cases and review of the literature. Clin Infect Dis 1996;22:262-7
53. Drutz DJ. Fungal infections of the kidney and urinary tract. In Schrier RW, Gottschalk CW eds. Diseases of the Kidney, 5th ed. Boston, Little, Brown, 1993;929-57
54. Wise GJ, Wainstein S, Goldbert P, Kozinn PJ. Candidal cystitis: Management by continuous bladder irrigation with amphotericin B. JAMA 1973;224:1636-7
55. Fisher JF, Hicks BC, Dipiro JT, et al. Efficacy of a single intravenous dose of amphotericin B in urinary tract infections caused by Candida. J Infect Dis 1987;156:685-7
56. Sanford JP. The enigma of candiduria: Evolution of bladder irrigation with amphotericin B for management - from anecdote to dogma and a lesson from Machiavelli. Clin Infect Dis 1993;16:145-7
57. Fisher JF, Newman CL, Sobel JD. Yeast in the urine: Solutions for a budding problem. Clin Infect Dis 1995;20:183-9
58. Fan-Havard P, O'Donovan C, Smith SM, et al. Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria. Clin Infect Dis 1995;21:960-5
59. Jacobs LG, Skidmore EA, Freeman K, et al. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients Clin Infect Dis 1996;22:30-5
60. Torres-Rojas JR, Stratton CW, Sanders CV, et al. Candidal suppurative peripheral thrombophlebitis Ann Intern Med 1982;96:431-5
61. Strinden WD, Helgerson RB, Maki DG. Candida septic thrombosis of the great central veins associated with central catheters. Ann Surg 1985;202:653-8
62. Kulak K, Maki DG. Treatment of Hickman catheter-related candidemia without removing the catheter Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, California. Washington, DC, American Society for Microbiology, 1992;831 (Abstract)
63. Thaler M, Pastakia B, Shawker TH, et al. Hepatic candidiasis in cancer patients: The evolving picture of the syndrome. Ann Intern Med 1988;108:88-100
64. Anaissie E, Bodey GP, Kantarjian H, et al. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 1991;91:142-50
65. Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 1989;149:2226-8
66. Rex JH, Rennett JE, Sugar AM, et al. Intravascular catheter exchange and duration of candidemia Clin Infect Dis 1995;21:994-6
67. Nguyen MH, Peacock JE, Tanner DC, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995;155:2429-35
68. Diego J, German M, Dunagan WC, et al. Management of Uncomplicated Candidemia with a Standardized Protocol of Amphotericin B. Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans. Washington DC, American Society for Microbiology, 1996;J92 (Abstract)
69. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990;12:308-29
70. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-30
71. Anaissie EJ, Darouiche RO, Abi-Said D, et al. Management of invasive candidial infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis 1996; 23:964-72
72. Anaissie EJ, Vartivarian SE, Abi-Said D, et al. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: A matched cohort study. Am J Med 1996; 101:170-6
73. Driessen M, Ellis JB, Cooper PA, et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis 1996;15:1107-12
74. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7
75. Kunova A, Trupl J, Dluholucky S, et al. Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species. Clin Infect Dis 1995;21:226-7
76. Iwen PC, Kelly DM, Reed EC, Hinrichs SH. Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole. Clin Infect Dis 1995;20: 342-7
77. Francis P, Walsh TJ. Evolving role of flucytosine in immunocompromised patients: New insights into safety, pharmacokinetics, and antifungal therapy. Clin Infect Dis 1992;15: 1003-18
78. Blumberg EA, Reboli AC. Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer. Clin Infect Dis 1996;22: 462-6
79. Girmenia C, Martino P, Cassone A. Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies. Blood 1996;87: 838-44
80. Simmons BP, Gelfand MS, Kritchevsky SB, et al. Decrease in candidemia rates associated with empiric use of Amphotericin B and flucouazole for nonsocomial fever of unknown origin. Infect Dis in Clin Pract 1997;6:177-181
81. Laguna F, Rodriguez-Tudela JL, Martinez-Suarez JV, et al. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans. Clin Infect Dis 1997;24:124-30
82. Ghannoum MA, Rex JH, Galgiani JN Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 1996;34:489-95
83. Nolte FS, Parkinson T, Falconer DJ, et al. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 1997;44:196-9
84. Powderly WG, Kobayashi GS, Herzig GP, Medoff G. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 1988;84:826-32
85. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992;326:845-51
86. Winston DJ, Chandrasekar PH, Lazsarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Ann Intern Med 1993;118:495-503